Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-01

Clinical Trial Update: Aciclovir Versus Placebo for HSV-2 Meningitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating aciclovir versus placebo for herpes simplex virus type 2 meningitis and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aciclovir (acyclovir)

Snippet

Sponsor: Jacob Bodilsen | Conditions: Herpes Simplex 2, Meningitis, Viral | Phase 4 | Status: NOT_YET_RECRUITING